Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

Background and Aim. EGFR is commonly expressed in cancers of the head and neck (H and N), and anti-EGFR agents have demonstrated improvements in outcomes (TTP and OS). The aim of this study was to determine EGFR gene status in H and N cancer patients treated with gefitinib and to correlate mutationa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Murray, Samuel, Bobos, Mattheos, Angouridakis, Nikolaos, Nikolaou, Angelos, Linardou, Helena, Razis, Evangelia, Fountzilas, George
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2010
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022192/
https://ncbi.nlm.nih.gov/pubmed/21274259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/709678
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares